Skip to content

Freeze-all

The freeze-all strategy in IVF: who benefits?

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON25760
Enrollment
900
Registered
2015-07-03
Start date
2015-09-01
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IVF, thawed embryo, progesterone, endometrium NL: IVF, ontdooien embryo, progesteron, endometrium

Interventions

Cryopreservation of all embryos at day 3-4 and postponed first transfer of the embryo in an unstimulated cycle. Cryopreservation of all supernumerary embryos and tranfser in unstimulated cycles. In bo

Sponsors

Academic Medical Center
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women between 18 and 43 years of age who start their first IVF/ICSI.

Exclusion criteria

Exclusion criteria: 1. Women undergoing a PGD cycle. 2. Women undergoing IVF in a modified natural cycle. 3. Women undergoing IVF for oocyte donation 4. Women undergoing ‘rescue’ IVF after overstimulation during IUI treatment. 5. Not able or willing to provide informed consent

Design outcomes

Primary

MeasureTime frame
Ongoing pregnancy rate per woman and progesterone serum level at day of ovulation trigger.

Secondary

MeasureTime frame
1. multiple ongoing pregnancy rates 2. live birth rates 3. cumulative ongoing pregnancy rates 4. time to pregnancy 5. costs 6. health-related quality of life (HRQL) 7. embryologic parameters: morphology, implantation rate 8. freeze-thaw survival per centre 9. endometrial parameters: thickness, appearance

Contacts

Public ContactF. Mol

Centrum voor Voortplantingsgeneeskunde Q3-119 Academisch Medisch Centrum

f.mol@amsterdamumc.nl020 5663557

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)